Bortezomib

Bortezomib-Induced Neuropathy From First to Second Treatment for Multiple Myeloma

Bortezomib-Induced Neuropathy From First to Second Treatment for Multiple Myeloma

By

Bortezomib-induced peripheral neuropathy does not worsen between initial treatment and retreatment in patients with multiple myeloma.

Sign Up for Free e-Newsletters